Cargando…
Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic represents a global threat, and the interaction between the virus and angiotensin-converting enzyme 2 (ACE2), the primary entry receptor for SARS-CoV-2, is a key determinant of the range of hosts that can be infected by the vi...
Autores principales: | Zhang, Hong-Liang, Li, Yu-Ming, Sun, Jing, Zhang, Yu-Yuan, Wang, Tong-Yun, Sun, Ming-Xia, Wang, Meng-Hang, Yang, Yue-Lin, Hu, Xiao-Liang, Tang, Yan-Dong, Zhao, Jincun, Cai, Xuehui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892319/ https://www.ncbi.nlm.nih.gov/pubmed/33610551 http://dx.doi.org/10.1016/j.jbc.2021.100435 |
Ejemplares similares
-
Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry
por: Hou, Yuxuan, et al.
Publicado: (2010) -
Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013) -
Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
por: Barker, Harlan, et al.
Publicado: (2020) -
Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020) -
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
por: Jiang, Fan, et al.
Publicado: (2014)